Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus

Lidia Serova, Mark Rivkin, Akira Nakashima, Esther L. Sabban

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Gender-specific differences in susceptibility to a number of disorders related to catecholaminergic systems, including depression and hypertension, have been postulated to be mediated, at least in part, by estrogens. In this study, we examined if estrogens may regulate gene expression of norepinephrine biosynthetic enzymes. Administration of five injections of 15 or 40 μg/kg estradiol benzoate to ovariectomized (OVX) female rats elicited a dose-dependent elevation in mRNA levels of tyrosine hydroxylase (TH) in locus coeruleus, to as great as 3-fold over control. Dopamine β-hydroxylase (DBH) mRNA levels were also similarly increased. To examine the mechanism, PC12 cells were cotransfected with luciferase reporter constructs under control of DBH or TH promoters [pDBH/Luc(-2,236/+21) or pTH/Luc(-272/+27 or -773/+27)] with an expression vector for estradiol receptor α. The cells were treated with 17β-estradiol (E2) for 12-36 h. E2 triggered a several fold increase in luciferase activity under control of the DBH promoter in a dose-dependent fashion. Omission of estrogen receptor α or addition of the estrogen receptor antagonist ICI 182,780 prevented the DBH promoter-driven increase in luciferase. When E2 was given with 0.2 mMCPT-cAMP, reporter activity with pDBH/Luc(-2,236/+21) was increased greater than with either treatment alone. In contrast, addition of E2 to cells transfected with pTH/Luc(-272/+27) elicited no change in basal luciferase activity nor in the response to 0.2 mM CPT-cAMP. These findings are the first to reveal that estrogen can stimulate DBH gene expression. Differing mechanisms may underlie the regulation of TH and DBH gene expression by estrogens.

Original languageEnglish
Pages (from-to)193-200
Number of pages8
JournalNeuroendocrinology
Volume75
Issue number3
DOIs
Publication statusPublished - 06-04-2002

Fingerprint

Locus Coeruleus
Luciferases
Estradiol
Norepinephrine
Estrogens
Tyrosine 3-Monooxygenase
Gene Expression
Enzymes
Estradiol Receptors
Messenger RNA
PC12 Cells
Mixed Function Oxygenases
Estrogen Receptors
Dopamine
Hypertension
Injections
Therapeutics

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Cite this

Serova, Lidia ; Rivkin, Mark ; Nakashima, Akira ; Sabban, Esther L. / Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus. In: Neuroendocrinology. 2002 ; Vol. 75, No. 3. pp. 193-200.
@article{5f079e11ef1840b38b25593d04e7feac,
title = "Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus",
abstract = "Gender-specific differences in susceptibility to a number of disorders related to catecholaminergic systems, including depression and hypertension, have been postulated to be mediated, at least in part, by estrogens. In this study, we examined if estrogens may regulate gene expression of norepinephrine biosynthetic enzymes. Administration of five injections of 15 or 40 μg/kg estradiol benzoate to ovariectomized (OVX) female rats elicited a dose-dependent elevation in mRNA levels of tyrosine hydroxylase (TH) in locus coeruleus, to as great as 3-fold over control. Dopamine β-hydroxylase (DBH) mRNA levels were also similarly increased. To examine the mechanism, PC12 cells were cotransfected with luciferase reporter constructs under control of DBH or TH promoters [pDBH/Luc(-2,236/+21) or pTH/Luc(-272/+27 or -773/+27)] with an expression vector for estradiol receptor α. The cells were treated with 17β-estradiol (E2) for 12-36 h. E2 triggered a several fold increase in luciferase activity under control of the DBH promoter in a dose-dependent fashion. Omission of estrogen receptor α or addition of the estrogen receptor antagonist ICI 182,780 prevented the DBH promoter-driven increase in luciferase. When E2 was given with 0.2 mMCPT-cAMP, reporter activity with pDBH/Luc(-2,236/+21) was increased greater than with either treatment alone. In contrast, addition of E2 to cells transfected with pTH/Luc(-272/+27) elicited no change in basal luciferase activity nor in the response to 0.2 mM CPT-cAMP. These findings are the first to reveal that estrogen can stimulate DBH gene expression. Differing mechanisms may underlie the regulation of TH and DBH gene expression by estrogens.",
author = "Lidia Serova and Mark Rivkin and Akira Nakashima and Sabban, {Esther L.}",
year = "2002",
month = "4",
day = "6",
doi = "10.1159/000048237",
language = "English",
volume = "75",
pages = "193--200",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "3",

}

Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus. / Serova, Lidia; Rivkin, Mark; Nakashima, Akira; Sabban, Esther L.

In: Neuroendocrinology, Vol. 75, No. 3, 06.04.2002, p. 193-200.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus

AU - Serova, Lidia

AU - Rivkin, Mark

AU - Nakashima, Akira

AU - Sabban, Esther L.

PY - 2002/4/6

Y1 - 2002/4/6

N2 - Gender-specific differences in susceptibility to a number of disorders related to catecholaminergic systems, including depression and hypertension, have been postulated to be mediated, at least in part, by estrogens. In this study, we examined if estrogens may regulate gene expression of norepinephrine biosynthetic enzymes. Administration of five injections of 15 or 40 μg/kg estradiol benzoate to ovariectomized (OVX) female rats elicited a dose-dependent elevation in mRNA levels of tyrosine hydroxylase (TH) in locus coeruleus, to as great as 3-fold over control. Dopamine β-hydroxylase (DBH) mRNA levels were also similarly increased. To examine the mechanism, PC12 cells were cotransfected with luciferase reporter constructs under control of DBH or TH promoters [pDBH/Luc(-2,236/+21) or pTH/Luc(-272/+27 or -773/+27)] with an expression vector for estradiol receptor α. The cells were treated with 17β-estradiol (E2) for 12-36 h. E2 triggered a several fold increase in luciferase activity under control of the DBH promoter in a dose-dependent fashion. Omission of estrogen receptor α or addition of the estrogen receptor antagonist ICI 182,780 prevented the DBH promoter-driven increase in luciferase. When E2 was given with 0.2 mMCPT-cAMP, reporter activity with pDBH/Luc(-2,236/+21) was increased greater than with either treatment alone. In contrast, addition of E2 to cells transfected with pTH/Luc(-272/+27) elicited no change in basal luciferase activity nor in the response to 0.2 mM CPT-cAMP. These findings are the first to reveal that estrogen can stimulate DBH gene expression. Differing mechanisms may underlie the regulation of TH and DBH gene expression by estrogens.

AB - Gender-specific differences in susceptibility to a number of disorders related to catecholaminergic systems, including depression and hypertension, have been postulated to be mediated, at least in part, by estrogens. In this study, we examined if estrogens may regulate gene expression of norepinephrine biosynthetic enzymes. Administration of five injections of 15 or 40 μg/kg estradiol benzoate to ovariectomized (OVX) female rats elicited a dose-dependent elevation in mRNA levels of tyrosine hydroxylase (TH) in locus coeruleus, to as great as 3-fold over control. Dopamine β-hydroxylase (DBH) mRNA levels were also similarly increased. To examine the mechanism, PC12 cells were cotransfected with luciferase reporter constructs under control of DBH or TH promoters [pDBH/Luc(-2,236/+21) or pTH/Luc(-272/+27 or -773/+27)] with an expression vector for estradiol receptor α. The cells were treated with 17β-estradiol (E2) for 12-36 h. E2 triggered a several fold increase in luciferase activity under control of the DBH promoter in a dose-dependent fashion. Omission of estrogen receptor α or addition of the estrogen receptor antagonist ICI 182,780 prevented the DBH promoter-driven increase in luciferase. When E2 was given with 0.2 mMCPT-cAMP, reporter activity with pDBH/Luc(-2,236/+21) was increased greater than with either treatment alone. In contrast, addition of E2 to cells transfected with pTH/Luc(-272/+27) elicited no change in basal luciferase activity nor in the response to 0.2 mM CPT-cAMP. These findings are the first to reveal that estrogen can stimulate DBH gene expression. Differing mechanisms may underlie the regulation of TH and DBH gene expression by estrogens.

UR - http://www.scopus.com/inward/record.url?scp=0036204238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036204238&partnerID=8YFLogxK

U2 - 10.1159/000048237

DO - 10.1159/000048237

M3 - Article

C2 - 11914591

AN - SCOPUS:0036204238

VL - 75

SP - 193

EP - 200

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 3

ER -